Department of Transfusion Medicine

Symposium Description

Thirty-Sixth Annual Symposium

Description: This program is designed to provide attendees with practical information about recent developments, current practices, controversies and laboratory management issues relative to transfusion medicine.

Who Should Attend: This program will be of interest to all healthcare providers who participate in the collection, production, transfusion and monitoring of blood products.

Learning Objectives
Upon the completion of this activity, participants should be able to:

  • Provide an update on the epidemiology of Zika virus and its impact on the United States blood supply.
  • List necessary steps and hurdles encountered when implementing the process of pathogen-reduction of apheresis platelet at blood centers and hospitals.
  • Summarize the evolution of the American Red Cross Hemovigilance Program and identify significant impacts on patient safety that have results from the program.
  • Develop appropriate patient and donor care strategies from examples described during case reviews.
  • Explain clinical outcomes and manufacturing challenges of CAR T cells.
  • Describe a flow-based assay to identify C1q bound HLA antibodies causing platelet transfusion refractoriness.
  • Review of the latest advances in treatment of congenital and acquired coagulopathy disorders.
  • Discuss hematopoietic stem cell transplantation for patients with sickle cell disease.

Level of Instruction
Intermediate to Advanced

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of ARCBS. Information is presented for educational purposes only.

Disclosure Statement
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflicts(s) of interest or other relationships related to the content of their presentation(s). Faculty are also expected to disclose off-label and/or investigational uses of products under discussion.

We gratefully acknowledge Saint-Gobain Performance Plastics, LifeSciences SBU and Immucor for providing educational grants in support of this continuing medical education activity.

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 06/14/2017

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at